Literature DB >> 28728305

[Incidence and mortality of stomach cancer in China, 2013].

S W Zhang1, Z X Yang1, R S Zheng1, H M Zeng1, W Q Chen1, J He2.   

Abstract

Objective: To estimate the incidence and mortality of stomach cancer in China based on the cancer registration data in 2013, collected by the National Central Cancer Registry (NCCR).
Methods: There were 347 cancer registries that submitted stomach cancer incidence and deaths occurred in 2013 to NCCR. After evaluating the data quality, 255 registries' data were accepted for analysis and stratified by areas (urban/rural), sex, and age group. Combined with data on national population in 2013, the nationwide incidence and mortality of stomach cancer were estimated. Chinese population census in 2000 and Segi's population were used for age-standardized incidence/mortality rates.
Results: Qualified 255 cancer registries covered a total of 226 494 490 populations (111 595 772 in urban and 114 898 718 in rural areas). The percentage of cases morphologically verified and death certificate-only cases were 76.27% and 1.98%, respectively, and the mortality to incidence rate ratio was 0.72. It is estimated that there were 427 000 new cases for stomach cancer nationwide, with a crude incidence rate of 31.38 per 100 000 (42.85 per 100 000 in males, 19.33 per 100 000 in females). The age-standardized incidence rates by Chinese standard population (ASR China) and by world standard population (ASR world) were 21.40 per 100 000 and 21.32 per 100 000, respectively, with a cumulative incidence rate (0-74 age years old) of 2.66%. The crude and ASR China incidence rates of stomach cancer in urban areas were 27.80 per 100 000 and 18.48 per 100 000, respectively, whereas those were 35.54 per 100 000 and 24.93 per 100 000 in rural areas. It is estimated that there were 301 000 deaths for stomach cancer nationwide, with a crude mortality rate of 22.13 per 100 000 (29.85 per 100 000 in males, 14.03 per 100 000 in females). The ASR China and ASR world mortality rates were 14.68 per 100 000 and 14.54 per 100 000, respectively, with a cumulative mortality rate (0-74 years old) of 1.70%. The crude and ASR China mortality rates were 18.94 per 100 000 and 12.20 per 100 000 in urban areas, respectively, whereas those were 25.84 per 100 000 and 17.67 per 100 000 in rural areas. Conclusions: There is still a heavy burden of stomach cancer in China. The burden and patterns of stomach cancer shows different gender and urban-rural differences. Prevention and control strategies should be implemented referring to local status.

Entities:  

Keywords:  China; Incidence; Mortality; Stomach neoplasms

Mesh:

Year:  2017        PMID: 28728305     DOI: 10.3760/cma.j.issn.0253-3766.2017.07.015

Source DB:  PubMed          Journal:  Zhonghua Zhong Liu Za Zhi        ISSN: 0253-3766


  9 in total

1.  Computed tomography-quantified body composition predicts short-term outcomes after gastrectomy in gastric cancer.

Authors:  Y Zhang; J P Wang; X L Wang; H Tian; T T Gao; L M Tang; F Tian; J W Wang; H J Zheng; L Zhang; X J Gao; G L Li; X Y Wang
Journal:  Curr Oncol       Date:  2018-10-31       Impact factor: 3.677

2.  Identification of critical genes in gastric cancer to predict prognosis using bioinformatics analysis methods.

Authors:  Jing Liu; Liang Ma; Zhiming Chen; Yao Song; Tinging Gu; Xianchen Liu; Hongyu Zhao; Ninghua Yao
Journal:  Ann Transl Med       Date:  2020-07

3.  Comparison of gastric cancer survival after R0 resection in the US and China.

Authors:  Ping Li; Chang-Ming Huang; Chao-Hui Zheng; Ashley Russo; Priyanka Kasbekar; Murray F Brennan; Daniel G Coit; Vivian E Strong
Journal:  J Surg Oncol       Date:  2018-10-17       Impact factor: 3.454

4.  National trend of gastric cancer mortality in China (2003-2015): a population-based study.

Authors:  Kun Gao; Jun Wu
Journal:  Cancer Commun (Lond)       Date:  2019-05-02

5.  Short-term outcomes of laparoscopic versus open proximal gastrectomy with double-tract reconstruction for Siewert type II and III adenocarcinoma of the esophagogastric junction: a retrospective observational study of consecutive patients.

Authors:  Fei Ma; Weifeng Wang; Dandan Guo; Yonglei Zhang; Liangqun Peng; Qi Ma; Sheqing Ji; Junhui Chai; Yawei Hua; Xiaobing Chen; Hui Wang; Shuning Xu; Qian Li; Suxia Luo; Hiroharu Yamashita; Kheng Tian Lim; Tian Li; Bin Zhang
Journal:  Ann Transl Med       Date:  2021-02

6.  Application of machine learning in the diagnosis of gastric cancer based on noninvasive characteristics.

Authors:  Shuang-Li Zhu; Jie Dong; Chenjing Zhang; Yao-Bo Huang; Wensheng Pan
Journal:  PLoS One       Date:  2020-12-31       Impact factor: 3.240

7.  Stoichiogenomics reveal oxygen usage bias, key proteins and pathways associated with stomach cancer.

Authors:  Xiaoyan Zuo; Bo Li; Chengxu Zhu; Zheng-Wen Yan; Miao Li; Xinyi Wang; Yu-Juan Zhang
Journal:  Sci Rep       Date:  2019-08-05       Impact factor: 4.996

8.  Elevated carbohydrate antigen 125 post-operation as a prognostic marker in gastric cancer patients with stage II-III.

Authors:  Jingjing Li; Qi Xu; Cong Luo; Lei Chen; Jieer Ying
Journal:  Transl Cancer Res       Date:  2020-09       Impact factor: 1.241

9.  Incidence and mortality of stomach cancer in China, 2014.

Authors:  Lei Yang; Rongshou Zheng; Ning Wang; Yannan Yuan; Shuo Liu; Huichao Li; Siwei Zhang; Hongmei Zeng; Wanqing Chen
Journal:  Chin J Cancer Res       Date:  2018-06       Impact factor: 5.087

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.